Tirzepatide has been associated with modest increases in resting heart rate (mean increase of 24 bpm in clinical trials), though the mechanism is unclear
[28] mhra.gov.uk or via the Yellow Card app), which helps monitor the safety of medicines and supplements in the UK
However, alcohol increases nausea risk, and the combination with tirzepatide might be poorly tolerated, particularly during the first few weeks on a new dose
Incretins are endogenous compounds, including GLP-1, that improve glycemic control once released into the circulation via the gut
Moreover, never stack the vials, as it can increase their risk of physical damage, such as cracking or stopper displacement